Researchers conducted a study to assess the immunogenicity of mRNA-based SARS-CoV-2 vaccines among patients with chronic inflammatory disease vs those with immunocompetence.
Researchers evaluated the outcomes of COVID-19 in patients with rheumatoid arthritis vs the general population, and also explored the outcomes among patients with RA, stratified by sex, race, and medications.
Investigators conducted a systemic review to assess the effects of various medications on seroconversion rates following SARS-CoV-2 vaccination in patients with immune mediated inflammatory disease.
In a qualitative study, researchers assessed the impact of COVID‐19 pandemic on the self‐care of patients with rheumatoid arthritis.
Increases seen in national standardized infection ratios for CLABSI, CAUTI, VAE, MRSA bacteremia.
In this case study, the authors highlighted the importance of tuberculous arthritis in the differential diagnoses of patients with persistent ankle swelling.
The American College of Rheumatology developed clinical guidance for the use of COVID-19 vaccines in patients with rheumatic and musculoskeletal diseases.
Researchers identified risk factors for serious infections in rheumatoid arthritis and validated the RABBIT risk score in real-life settings.
An overview of the risk for infections during targeted and biological therapies in rheumatoid arthritis and psoriatic arthritis.
The COVID-19 Global Rheumatology Alliance Patient Experience Survey was used to assess the effect of antimalarial drug shortages during the COVID-19 pandemic.
